Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines

Keyphrases

• COVID-19 Pandemic 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 Variants 100%
• VOCs 100%
• BA.1 100%
• COVID-19 mRNA Vaccine 100%
• Neutralizing Activity 50%
• Vaccination 50%
• Effective Strategies 50%
• Vaccine Response 50%
• Revaccination 50%
• Lambda 50%
• Potential Impact 50%
• COVID-19 50%
• Beta-gamma 50%
• Third Dose 50%
• Gamma delta 50%
• Differential Reduction 50%
• MRNA Vaccine 50%
• Variants of Concern 50%
• Omicron Variant 50%
• Vaccine Booster 50%
• BA.2 50%
• International Authority 50%
• National Authorities 50%

Immunology and Microbiology

• Neutralization 100%
• COVID-19 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Immunology 100%
• Omicron Coronavirus Variant 66%
• Lineages 33%
• Booster Dose 33%